Center for Global Health Policy’s “Science Speaks”: HLM 2016 AIDS: TB gets time and targets, as leaders weigh impacts of No. 1 killer
Antigone Barton, senior writer and editor of “Science Speaks,” reports on a discussion last week during which health ministers and global health leaders talked about “disconnects that continue to surround efforts to address tuberculosis and HIV together, between medical and community responses, as well as within medical and community responses — keeping screening and diagnosis for the two diseases apart…” (6/10).

Center for Global Health Policy’s “Science Speaks”: HLM 2016 AIDS: Universal treatment access panel looks at issues in generic antiretroviral medicines
Christine Lubinski, executive director of the Center for Global Health Policy, discusses remarks made at a session during which Ren Mingui, assistant director general for HIV/AIDS, Tuberculosis, Malaria, and Neglected Tropical Diseases at the WHO, discussed manufacturing generic antiretroviral drugs. Lubinski writes, “Incentivizing more companies to participate, supporting regional and local capacity to develop, manufacture, and deliver quality-assured generic medicines, simplifying treatments, and looking for cost efficiencies in other components of HIV care are among the actions he said will be necessary to ensure access to these medicines for those who live in low-income countries” (6/10).

Friends of the Global Fight Blog: AIDS is a crisis: What everyone should know from the 2016 High-Level Meeting on Ending AIDS
This blog post highlights tweets related to and key points made at the 2016 High-Level Meeting on Ending AIDS (6/10).